MoneyWorks4Me

Oxygenta Pharmaceutical informs about disclosure

18 Apr 2024 Evaluate
Oxygenta Pharmaceutical has informed that it enclosed a copy of Detailed Public Statement under Regulations 13(4), 14(3) and 15(2) of The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended for the attention of the eligible Equity Shareholders of Oxygenta Pharmaceutical (Target Company).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..